Navamedic launches Virono®- the first single-dose over-the-counter cold sore tablet

OSLO, Norway, May 22, 2026 /PRNewswire/ -- Navamedic ASA (OSE: NAVA) today announces the launch of Virono®, the first over-the-counter single-dose treatment for recurrent cold sores (herpes labialis) in adults. The launch establishes a new OTC treatment category and represents an...